Ho-Jin Shin

7PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematologyMedical mycologyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2026
Efficacy and safety of the BEBM (bendamustine, etoposide, busulfan, and melphalan) conditioning regimen for autologous stem-cell transplantation in non-Hodgkin lymphoma.

|Dec 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL).

Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin

|Oct 24, 2023
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea.

Jin Seok Kim, Jun Ho Jang, Deog-Yeon Jo

|Feb 07, 2020
Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma.

Do Young Kim, Joo-Seop Chung, Jae-Cheol Jo

|Nov 01, 2019
Neutropenic Enterocolitis due to Mucormycosis in a Patient with Myelodysplastic Syndrome.

Joon Woo Park, Joo Seop Chung, Shinwon Lee

|May 04, 2019
Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment

Su-Hee Cho, Ho-Jin Shin, Ki Sun Jung

Pageof 2

Frequent Collaborators

2 joint publications

Do Young Kim

2 joint publications

Jin Seok Kim

1 joint publications

Joon Woo Park

1 joint publications

Joo Seop Chung